Search for a command to run...
1. Alzheimer's disease (AD) is characterized by mitochondrial dysfunction and amyloid-beta deposition. In 2025, exosome-mediated delivery of VGF mRNA was shown to significantly improve mitochondrial bioenergetics and electrophysiological activity in SH-SY5Y cells and preliminary iPSC-derived organoids (DCPS Science Fair 11th Grade 2nd Place, Mayo Clinic SPARK Alumnus). However, Aβ42 reduction remained non-significant due to limited 3D penetration (P > 0.05). This continuation project proposes to further extend Yaya’s 2025 validated EV-mediated VGF mRNA delivery results into 3D organoid cross-pathology models and introduces a magnetic-controlled silk fibroin tadpole active delivery system as Phase 2 to address the penetration bottleneck. No new experiments were performed in 2026; this proposal is based on 2025 validated results and is planned for 2027 extension. 2. This report consolidates the developmental trajectory and technical specifications of the Magnetic Silk Fibroin Adaptive Robot (MSAR) platform. By integrating a 6-day mitochondrial "reset" protocol with 3D necroprinting technology using native mosquito proboscises, the MSAR platform addresses the 3D tissue penetration bottleneck (P > 0.05) identified in 2025. This document serves as a formal record of the "Consanguineous Trio"—the convergence of familial scientific heritage and independent engineering innovation.